REPORT ISPOR Brasil 2019
Transcript of REPORT ISPOR Brasil 2019
![Page 1: REPORT ISPOR Brasil 2019](https://reader031.fdocuments.us/reader031/viewer/2022012416/61715e8586bca167ce6415ff/html5/thumbnails/1.jpg)
REPORT ISPOR Brasil 2019
![Page 2: REPORT ISPOR Brasil 2019](https://reader031.fdocuments.us/reader031/viewer/2022012416/61715e8586bca167ce6415ff/html5/thumbnails/2.jpg)
ISPOR BRASIL BOARD 2018-2021
PRESIDENT
Stephen Doral Stefani
VICE PRESIDENT
Wilson Follador
CHAIRMAN OF THE DELIBERATIVE COUNCIL
Marco Antonio dos Santos
EDUCATIONAL DIRECTOR
Manoel Carlos Líbano dos Santos
DIRECTOR OF INSTITUTIONAL PUBLIC RELATIONS
Elio Tanaka
DIRECTOR OF INDICATORS
Juliana Martinho Busch
DIRECTOR OF PROJECTS AND EVENTS
Gabriela Tannus Branco de Araújo
DIRECTOR OF INSTITUTIONAL RELATIONS
Marcelo Cunio Machado Fonseca
TREASURER
Dayan Sansone
![Page 3: REPORT ISPOR Brasil 2019](https://reader031.fdocuments.us/reader031/viewer/2022012416/61715e8586bca167ce6415ff/html5/thumbnails/3.jpg)
LATAM 2019
• Jens Grueger, Stephen Stefani (ISPOR Brasil president), Lou Garrison, Rogério Scarabel (ANS) e Sean Sullivan
![Page 4: REPORT ISPOR Brasil 2019](https://reader031.fdocuments.us/reader031/viewer/2022012416/61715e8586bca167ce6415ff/html5/thumbnails/4.jpg)
Fórum para Gestores da Saúde SuplementarBogotá-Colombia
• Manoel Carlos (educational director), Stephen Stefani (president), Wilson Follador (vice president) e Juliana Busch (director of indicators)
![Page 5: REPORT ISPOR Brasil 2019](https://reader031.fdocuments.us/reader031/viewer/2022012416/61715e8586bca167ce6415ff/html5/thumbnails/5.jpg)
FÓRUM SUL ONCOGUIA
Stephen Doral Stephani
![Page 6: REPORT ISPOR Brasil 2019](https://reader031.fdocuments.us/reader031/viewer/2022012416/61715e8586bca167ce6415ff/html5/thumbnails/6.jpg)
ISPOR BRASIL IN THE PRESS
![Page 7: REPORT ISPOR Brasil 2019](https://reader031.fdocuments.us/reader031/viewer/2022012416/61715e8586bca167ce6415ff/html5/thumbnails/7.jpg)
Access to new treatments by SUS is still an obstacle – O Estado de S. Paulo
Press
![Page 8: REPORT ISPOR Brasil 2019](https://reader031.fdocuments.us/reader031/viewer/2022012416/61715e8586bca167ce6415ff/html5/thumbnails/8.jpg)
Amid the disregard for science, Biosimilar that enables advanced cancer therapy represents a technological leap for Brazil
Press
![Page 9: REPORT ISPOR Brasil 2019](https://reader031.fdocuments.us/reader031/viewer/2022012416/61715e8586bca167ce6415ff/html5/thumbnails/9.jpg)
Population Aging: Conquest or Problem? – Value & Outcomes Spotlight
Press
![Page 10: REPORT ISPOR Brasil 2019](https://reader031.fdocuments.us/reader031/viewer/2022012416/61715e8586bca167ce6415ff/html5/thumbnails/10.jpg)
New Challenges in Oncology for the Brazilian Private Health Sector: Specialists' Concerns After the ISPOR International Congress in Boston, Massachusetts, 2017–Value in Health Regional Issues
Press
![Page 11: REPORT ISPOR Brasil 2019](https://reader031.fdocuments.us/reader031/viewer/2022012416/61715e8586bca167ce6415ff/html5/thumbnails/11.jpg)
CERTIFICATES
![Page 12: REPORT ISPOR Brasil 2019](https://reader031.fdocuments.us/reader031/viewer/2022012416/61715e8586bca167ce6415ff/html5/thumbnails/12.jpg)
CERTIFICATE OF
PARTICIPATION